Top Medical Stocks To Buy Right Now

Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry

Merck’s Keytruda Achieves Success In Phase 3 Study As A Combo Therapy

News: On Tuesday, Merck (MRK) announced positive results in a phase 3 study, using a combination of Keytruda and Alimta, treating patients with previously untreated non-small cell lung cancer (NSCLC). Alimta is a lung cancer drug developed by Eli Lilly (LLY). The phase 3 study, named Keynote-189, met on both endpoints of the study. The combo improved progression-free survival and overall-survival in patients.

Analysis: This news is really good for Merck. Not only did it report positive results for this indication, but it did so very early. That’s because this was just an interim look at the data. The final data for this trial was not expected until early 2019. The news might get even better, because this was just top-line results that were reported. The full set of detailed data from this study won’t be revealed until an upcoming medical conference. That means that investors have a lot to look forward too. This also trumps the notion that a Keytruda- chemo combo won’t work for first-line lung cancer. That’s because Merck pulled its European application last year for a Keytruda-chemo combo, because of results from a small phase 2 study. At that time, everyone was placing bets that the phase 3 study would also not show impressive data. Well, as you can see Merck has proved everyone wrong, and now it has a lot to hang its hat on. This win for Merck is bad for both Roche (OTCQX:RHHBY) and Bristol-Myers Squibb (BMY) which is why both traded lower as soon as the Merck results were announced.

Top Medical Stocks To Buy Right Now: First Choice Healthcare Solutions, Inc. (FCHS)

Advisors’ Opinion:

  • [By Logan Wallace]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare First Choice Healthcare Solutions to related businesses based on the strength of its risk, valuation, profitability, earnings, analyst recommendations, dividends and institutional ownership.

  • [By Logan Wallace]

    Telsey Advisory Group assumed coverage on shares of First Choice Healthcare Solutions (OTCMKTS:FCHS). Telsey Advisory Group issued a buy rating on the stock.

  • [By Logan Wallace]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare First Choice Healthcare Solutions to related businesses based on the strength of its risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations.

Top Medical Stocks To Buy Right Now: American States Water Company(AWR)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    There’s no guesswork involved, and the best part is – it’ll only take you 10 minutes per day! Click here now to start this once-in-a-lifetime journey…

    Stocks to Watch Today: KHC, HD, JWN, M, AAPL
    Kraft Heinz Co. (NYSE: KHC) is still licking its wounds after an abysmal earnings report on Thursday and a weak 2019 outlook. The consumer goods giant is looking to reshape its business as consumer tastes continue to evolve. According to reports, the firm – backed heavily by Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.A) – is considering a deal to sell its Maxwell House brand. Warren Buffett is also affecting shares of Apple Inc. (NASDAQ: AAPL). Although AAPL stock added 0.4% in pre-market hours, Buffett said he would not purchase more shares of the company stock at these levels. However, should AAPL stock pull back in the near future, the “Oracle of Omaha” would consider purchasing more. Earnings season may be winding down, but concerns about the U.S. brick-and-mortar retail industry are always high. This week, Home Depot Inc. (NYSE: HD), Nordstrom Inc. (NYSE: JWN), and Macy’s Inc. (NYSE: M) will report earnings from the holiday quarter. Look for earnings reports from American States Water Co. (NYSE: AWR), Chatham Lodging Trust (NYSE: CLDT), EPR Properties (NYSE: EPR), Etsy Inc. (NASDAQ: ETSY), Life Storage Inc. (NYSE: LSI), Mosaic Co. (NYSE: MOS), Oneok Inc. (NYSE: OKE), Potbelly Corp. (NASDAQ: PBPB), Preferred Apartment Communities Inc. (NYSE: APTS), Rent-A-Center Inc. (NASDAQ: RCII), Shake Shack Inc. (NYSE: SHAK), and Tenet Healthcare Corp. (NYSE: THC).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Neha Chamaria]

    In terms of dividend growth, only four of the above stocks — 3M, Colgate-Palmolive, Coca-Cola, and Procter & Gamble — feature among the 10 fastest dividend-growth kings. In other words, there are six other stocks from the dividend kings list that have grown their dividends at a faster pace than most stocks in the above table in the past decade, some even at double-digits.  

    Six top dividend kings by dividend growth

    Dividend King 10-Year Dividend CAGR Current Dividend Yield Payout Ratio (TTM)
    Lowe’s Companies  18.5% 2% 34.5%
    Hormel Foods  16.3% 2.1% 39.2%
    Parker-Hannifin Corp (NYSE:PH) 14% 1.7% 35.2%
    Nordson Corporation  12.2% 0.9% 13.3%
    Dover Corp (NYSE:DOV) 9% 2% 37.4%
    American States Water (NYSE:AWR) 7.6% 1.9% 54.8%

    TTM: Trailing 12 months. Data sources: YCharts and Yahoo! Finance. Table by author.

  • [By Neha Chamaria and Jason Hall]

    Two such amazing but little-known dividend-paying companies that our Motley Fool contributors have identified are American States Water (NYSE:AWR) and Caretrust REIT Inc. (NASDAQ:CTRE). Read along to know why you should have these stocks on your radar.

  • [By Motley Fool Transcribing]

    American States Water (NYSE:AWR) Q4 2018 Earnings Conference CallFeb. 26, 2019 2:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Medical Stocks To Buy Right Now: AdvanSix Inc. (ASIX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Algert Global LLC trimmed its position in shares of AdvanSix Inc (NYSE:ASIX) by 58.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,001 shares of the company’s stock after selling 29,859 shares during the period. Algert Global LLC owned about 0.07% of AdvanSix worth $511,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    AdvanSix (NYSE:ASIX) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday.

  • [By Max Byerly]

    AdvanSix (NYSE:ASIX) Director Michael Marberry bought 1,398 shares of the stock in a transaction on Monday, May 7th. The stock was purchased at an average price of $35.74 per share, for a total transaction of $49,964.52. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

  • [By Ethan Ryder]

    GSA Capital Partners LLP reduced its holdings in AdvanSix Inc (NYSE:ASIX) by 36.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 24,620 shares of the company’s stock after selling 14,277 shares during the quarter. GSA Capital Partners LLP owned about 0.08% of AdvanSix worth $856,000 as of its most recent filing with the SEC.

Top Medical Stocks To Buy Right Now: Akamai Technologies, Inc.(AKAM)

Advisors’ Opinion:

  • [By Anders Bylund]

    During the first quarter, Limelight settled the last of its legal battles with rival Akamai Technologies (NASDAQ:AKAM). The terms of this settlement were not publicly addressed, but Limelight was the plaintiff and Akamai the defendant in the last patent infringement case, though Akamai also returned fire with several counterclaims. If the settlement had any financial effects, we’ll see those on Akamai’s and Limelight’s financial statements over time. If not, the two companies just removed a source of financial uncertainty.

  • [By ]

    There could be a for sale sign planted in the ground at tech pioneer Akamai (AKAM) .

    “We’re a public company and our board, which is very professional and diligent, is always going to do the right thing for shareholders,” Akamai CEO Tom Leighton told TheStreet when asked if the company he co-founded in 1998 was for sale. While Leighton left the door open on a possible sale, he added that Akamai has strong prospects as a stand-alone company as well.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Akamai Technologies (AKAM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Akamai Technologies, Inc. (NASDAQ:AKAM)’s share price reached a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $81.46 and last traded at $81.47, with a volume of 38096 shares traded. The stock had previously closed at $81.23.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Akamai Technologies, Inc. (NASDAQ: AKAM) which rose about 7% to $74.89. The stock’s 52-week range is $44.65 to $75.00. Volume was roughly 4 million compared to the daily average volume of 2.3 million.

  • [By Garrett Baldwin]

    Click here to learn more.

    Stocks to Watch Today: GILD, AMZN, UAA, JPM, AAPL, NFLX
    Shares of Gilead Sciences Inc. (NASDAQ: GILD) fell 2.4% after the biotech giant announced disappointing results from a trial for a drug for chronic liver disease. In deal news, Amazon.com Inc. (NASDAQ: AMZN) will buy Wi-Fi/home router startup Eero for an undisclosed amount. The global e-commerce giant has been going on a smart-home acquisition streak. Last year, the firm bought video doorbell maker Ring for $1 billion. Eero is based in San Francisco and was founded in 2014. The firm makes mesh routers that aim to eliminate dead zones across a house or business location. Shares of Under Armour Inc. (NYSE: UAA) gained more than 2.2% after the company reported earnings before the bell. The sports apparel giant reported earnings per share of $0.09 (on an adjusted basis). That figure beat expectations of $0.04. The company’s sales were off about 6% in the fourth quarter but cited a big jump in foreign revenue. Last week, JPMorgan Chase & Co. (NYSE: JPM) released a report that recommended one of the deals of the decade. The bank has called for Apple Inc. (NASDAQ: AAPL) to buy streaming giant Netflix Inc. (NASDAQ: NFLX). This deal is a no-brainer in today’s market. We break down what a deal would look like, how it benefits both sides, and how it would be like rocket fuel for Apple stock. Here’s what you need to know. Look for earnings reports from Activision Blizzard Inc. (NASDAQ: ATVI), Aircastle Ltd. (NYSE: AYR), Akamai Technologies Inc. (NASDAQ: AKAM), Ares Capital Corp. (NASDAQ: ARCC), Denny’s Corp. (NASDAQ: DENN), Groupon Inc. (NASDAQ: GRPN), HubSpot Inc. (NASDAQ: HUBS), Molson Coors Brewing Co. (NYSE: TAP), Occidental Petroleum Corp. (NYSE: OXY), Shopify Inc. (NASDAQ: SHOP), and TripAdvisor Inc. (NASDAQ: TRIP).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

Top Medical Stocks To Buy Right Now: United Technologies Corporation(UTX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:

    Get United Technologies alerts:

    United Technologies Co. (UTX) Receives Consensus Rating of “Buy” from Brokerages (americanbankingnews.com) United Technologies (UTX) & TAT Technologies (TATT) Head to Head Comparison (americanbankingnews.com) United Technologies to Sell Ice Cream-Machine Manufacturer for $1 Billion (wsj.com) United Technologies Sells Ice-Cream Machine Unit for $1 Billion (finance.yahoo.com) [$$] United Technologies to Sell Ice Cream-Machine Manufacturer for $1 Billion (finance.yahoo.com)

    A number of research firms have recently commented on UTX. ValuEngine upgraded United Technologies from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Cowen reiterated a “hold” rating and issued a $141.00 price objective on shares of United Technologies in a research note on Thursday, January 25th. Stifel Nicolaus reiterated a “hold” rating and issued a $146.00 price objective (up from $124.00) on shares of United Technologies in a research note on Thursday, January 25th. Sanford C. Bernstein reiterated a “positive” rating and issued a $153.00 price objective (up from $135.00) on shares of United Technologies in a research note on Tuesday, January 30th. Finally, Zacks Investment Research lowered United Technologies from a “buy” rating to a “hold” rating in a research note on Monday, January 22nd. Nine equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $138.21.

  • [By Paul Ausick]

    United Technologies Corp. (NYSE: UTX) traded down 1.65% at $134.32. The stock’s 52-week range is $106.85 to $137.39. Volume was about 15% above the daily average of around 3.1 million. The company had no specific news Tuesday.

  • [By Max Byerly]

    Daiwa Securities Group Inc. raised its holdings in shares of United Technologies Co. (NYSE:UTX) by 10.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 63,924 shares of the conglomerate’s stock after purchasing an additional 5,852 shares during the quarter. Daiwa Securities Group Inc.’s holdings in United Technologies were worth $8,042,000 as of its most recent SEC filing.

  • [By Paul Ausick]

    United Technologies Corp. (NYSE: UTX) traded up 1.50% at $130.92. The stock’s 52-week range is $109.10 to $139.24. Volume was about 15% below the daily average of around 3.9 million shares.

  • [By Lee Samaha]

    First, commercial aviation markets have been stronger than most people expected coming into 2018. Strong aerospace markets are behind Honeywell International and United Technologies (NYSE:UTX)  beating earnings expectations in 2018, and as you can see below that GE Aviation aftermarket sales continued to grow at a near 20% rate in the first half.

  • [By Sean Williams]

    Below is a list of all 30 current Dow components ranked, according to the date they were added, or most recently added (assuming they’ve bounced in and out of the index like GE), to the index.

    ExxonMobil (NYSE:XOM): Added Oct. 1, 1928 Procter & Gamble (NYSE:PG): Added May 26, 1932 DowDuPont (NYSE:DWDP): Added Nov. 20, 1935 United Technologies (NYSE:UTX): Added March 4, 1939 3M: Added Aug. 9, 1976 IBM: Added June 29, 1979 Merck: Added Jun. 29, 1979 American Express: Added Aug. 30, 1982 McDonald’s: Added Oct. 30, 1985 Boeing: Added March 12, 1987 Coca-Cola: Added March 12, 1987 Caterpillar: Added May 6, 1991 JPMorgan Chase: Added May 6, 1991 Walt Disney: Added May 6, 1991 Johnson & Johnson: Added March 17, 1997 Walmart: Added March 17, 1997 Home Depot: Added Nov. 1, 1999 Intel: Added Nov. 1, 1999 Microsoft: Added Nov. 1, 1999 Pfizer: Added April 8, 2004 Verizon: Added April 8, 2004 Chevron: Added Feb. 19, 2008 Cisco Systems: Added June 8, 2009 Travelers Cos.: Added June 8, 2009 UnitedHealth Group: Added Sept. 24, 2012 Goldman Sachs: Added Sept. 23, 2013 Nike: Added Sept. 23, 2013 Visa: Added Sept. 23, 2013 Apple: Added March 19, 2015 Walgreens Boots Alliance: Added Jun. 26, 2018

    As you’ll note, a third of the components have only been part of the Dow for the past 14 years. Just four components — ExxonMobil, Procter & Gamble, DowDuPont, and United Technologies — have been included for more than 42 consecutive years.

Top Medical Stocks To Buy Right Now: Cohen & Steers Select Preferred and Income Fund, Inc.(PSF)

Advisors’ Opinion:

  • [By Max Byerly]

    Media stories about Cohen & Steers Select Pref & Inc Fd (NYSE:PSF) have trended positive recently, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cohen & Steers Select Pref & Inc Fd earned a media sentiment score of 0.39 on Accern’s scale. Accern also gave headlines about the company an impact score of 48.661768322942 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Leave a Reply

Your email address will not be published. Required fields are marked *